CA9 and renal cell adenocarcinoma: In a lung metastasis model of human RCC in mice, the combination of anti-CAIX CAR T cells with sunitinib resulted in the survival of all mice at the end of the experiments and decreased tumor burden, with improved infiltration and proliferation of CAR T cells followed by 50% reduction in myeloid-derived suppressor cells (MDSCs) infiltration.